Mortality risk prediction by an insurance company and long-term follow-up of 62,000 men

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Sijbrands, Eric J G ^a   Tornij, Erik ^b   Homsma, Sietske J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ING Group   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ALGORITHM; ARTICLE; CONTROLLED STUDY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INSURANCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MORTALITY; NETHERLANDS; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; ADOLESCENT; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HEALTH SURVEY; LUNG DISEASE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; INSURANCE CARRIERS; INSURANCE, LIFE; LUNG DISEASES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK ASSESSMENT; SURVIVAL RATE; YOUNG ADULT;

EID: 65549171553     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005457     Document Type: Article

References (29)

1. Singer RB (1998) Chapter 4: The application of life table methodology to risk appraisal. In: Brackenbridge RDC, Elder WJ, eds. Medical selection of life risk. 4th ed. London, United Kingdom: MacMillan Reference Ltd. pp 37-60.
2. Gleeson RK (2004) Chaptor 4: Medical underwriting. In: Rothstein MA, ed. Genetics and life insurance. Medical underwriting and social policy. Cambridge, United Kingdom: Massachusetts Institute of Technology. pp 73-94.
3. Rothenberg RB (1994) Competing mortality and progress against cancer. Epidemiology 5: 197-203.
4. Clayton EW (2003) Ethical, legal, and social implications of genomic medicine. New Engl J Med 349: 562-569.
5. Ossa DF, Towse A (2004) Genetic screening, health care and the insurance industry. Should genetic information be made available to insurers? Eur J Health Econom 5: 116-121.
6. Mayor S (2005) UK insurers postpone using predictive genetic testing until 2011. BMJ 330: 617.
7. Morrison PJ (2005) Insurance, unfair discrimination, and genetic testing. Lancet 366: 877-880.
8. Sijbrands EJG, Westendorp RGJ, Defesche JC, de Meijer PHEM, Smelt AHM, et al. (2001) Mortality over two centuries in a large pedigree with familial hypercholesterolaemia. BMJ 322: 1019-1023.
9. Hoes AW, Grobbee DE, Valkenburg HA, Lubsen J, Hofman A (1993) Cardiovascular risk and all-cause mortality; a 12 year follow-up study in the Netherlands. Eur J Epidemiol 9: 285-292.
10. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847.
11. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105: 310-315.
12. Tunbridge WMG (1981) Factors contributing to deaths of diabetics under 50 years of age. Lancet II: 569-572.
13. Fuller JH, Elford J, Goldblatt P, Adelstein AM (1983) Diabetes mortality: new light on an underestimated public health problem. Diabetologia 24: 336-341.
14. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, et al. (1987) Magnitude and determinants of coronary artery disease in juvenile onset, insulin-dependent diabetes mellitus. Am J Cardiol 59: 750-755.
15. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, et al. (1988) Mortality among diabetics in a national sample. Am J Epidemiol 128: 389-401.
16. Sytkowski PA, Kannel WB, D'Agostino RB (1990) Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 322: 1635-1641.
17. (1988) The report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 148: 1023-1038.
18. Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, et al. (1985) Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 72: V71-V78.
19. Coleman MP, Herman C, Douglas A (1989) Person-years (PYRS):a further program for cohort study analysis. Lyons: WHO.
20. Kendal DG (1962) Rank Correlation Methods. 3rd ed. London, UK: Charles Griffin. 199 p.
21. Steyerberg EW, Harrell Jr FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, et al. (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54: 774-781.
22. Carragee EJ (2005) Persistant low back pain. N Engl J Med 352: 1891-1898.
23. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952.
24. Khoury MJ, McCabe LL, McGabe RB (2003) Population screening in the age of genomic medicine. New Engl J Med 348: 50-58.
25. Raithatha N, Smith RD (2004) Disclosure of genetic tests for health insurance: is it ethical not to? Lancet 363: 395-396.
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572.
27. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, et al. (2000) The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 342: 1-8.
28. Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, et al. (2001) Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999. Diabetes Care 24: 823-827.
29. Asao K, Sarti C, Forsen T, Hyttinen V, Nishimura R, et al. (2003) Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 26: 2037-2042.